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Abstract: ToChLPV and PepGMV are Begomoviruses that have adapted to a wide host 
range and are able to cause major diseases in agronomic crops. We analyzed the efficacy of 
induced resistance to PepGMV in Nicotiana benthamiana plants with two constructs: one 
construct with homologous sequences derived from PepGMV, and the other construct with 
heterologous sequences derived from ToChLPV. Plants protected with the heterologous 
construct showed an efficacy to decrease the severity of symptoms of 45%, while plants 
protected with the homologous construct showed an efficacy of 80%. Plants protected with 
the heterologous construct showed a reduction of incidence of 42.86%, while the reduction 
of incidence in plants protected with the homologous construct was 57.15%. The efficacy 
to decrease viral load was 95.6% in plants protected with the heterologous construct, and 
99.56% in plants protected with the homologous construct. We found, in both constructs, 
up-regulated key components of the RNAi pathway. This demonstrates that the efficacy of 
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the constructs was due to the activation of the gene silencing mechanism, and is reflected 
in the decrease of viral genome copies, as well as in recovery phenotype. We present 
evidence that both constructs are functional and can efficiently induce transient resistance 
against PepGMV infections. This observation guarantees a further exploration as a strategy 
to control complex Begomovirus diseases in the field. 
 
Keywords: Hairpin RNA; Mixed infections; PepGMV; RNAi constructs; ToChLPV; Viral 
load 
 
 
1. Introduction 
 
Begomovirus is the largest genus in the Geminiviridae family and includes approximately 192 
species that infect dicot plants; are transmitted by the Bemisia tabaci whitefly species complex, and 
can be either monopartite (containing a single DNA-A component) or bipartite (DNA-A and DNA-B) 
[1]. In the last two decades, Begomoviruses have become one of the most important groups of plant 
viruses in tropical and subtropical regions and are responsible for the emergence of new diseases that 
cause important yield losses [2, 3]. Pepper golden mosaic virus (PepGMV) is one of the most widely 
distributed Begomoviruses species affecting tomato (Solanum lycopersicum L.), and pepper (Capsicum 
annuum L.) and it is disseminated over a large geographic area spanning southwestern United States, 
Mexico and Central America [4]. PepGMV, has been found co-infecting tomato with the bipartite 
Begomoviruses Pepper huasteco yellow vein virus (PHYVV) [5, 6] and Tomato yellow leaf curl virus 
(TYLCV) [7]. These co-infections appear as the most devastating viral disease in Mexico with 
important epidemiological implications since the disease spreads faster and causes more severe 
symptoms than those caused by single infections. Mixed viral infections have been increasingly found 
in a wide range of hosts, including pepper, tomato, green tomato, “tomatillo” (Physalis ixocarpa Brot.) 
and tobacco [4, 5]. Another virus, the Tomato chino La Paz virus (ToChLPV), has been found 
infecting tomato plants in the Baja California Peninsula [8]. In addition, ToChLPV was found in  
co-infection with TYLCV in tomato and tomatillo, Mexican thistle (Solanum rostratum Dunal), and 
pepper plants in Sinaloa, San Luis Potosi, and Baja California Sur, respectively [9, 10, 11]. The 
presence of these interacting viruses represent a risk for the emergence of new and complex diseases, 
and have important implications in the sustainable control systems of the disease [3, 12, 13].  
A biotechnological tool that has been used to induce pathogen-derived resistance against 
begomoviral diseases in plants is the RNA interference (RNAi) [14-16]. RNAi is a very adaptable 
strategy because its specificity is dictated by the sequence of the viral genome itself, and the small 
interference RNA (siRNA) that serves as a guide and can down-regulate gene expression and viral 
DNA accumulation [17]. A variety of geminivirus resistance strategies have been tested such as the 
expression of mutated viral proteins [18], antisense RNAi silencing transcript of viral sequences 
[15,19], 21–25 nt-long siRNAs [20], artificial micro-RNAs (amiRNAs) [21], and chimeric transgene 
constructs [22]. Commonly, these RNAi strategies have been used successfully with the entire, partial 
or mutated sequences of AC1 (Rep) or AV1 (CP) genes and the non-coding intergenic region (IR)  
[23-25]. The AV1 gene was the first gene to confer resistance against homologous viral infections 
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(closely related species) and remains one of the most widely used. In some cases protection is broad 
and effective against several strains of the virus from which the AV1 gene is derived [23]. However, 
this strategy has not resulted in a significant level of resistance for bipartite Begomoviruses. The AC1 
gene has been an excellent target to generate broad resistance because it: i) is highly conserved; ii) is 
involved in the modulation of geminiviral gene expression, and iii) would impact viral replication by 
reducing viral DNA accumulation [26-29]. 
Effects and effectiveness to evaluate transgenes are commonly based on severity of symptoms and 
incidence of the disease, which are analyzed by PCR and dot blot hybridization [30]. In addition to 
results based only on visual assessments and qualitative or semi-quantitative data generating only 
subjective results, interactions of other intrinsic features such as recognition of specific targets, 
symptoms recovery and viral DNA accumulation are difficult to unravel [31]. Real-time PCR (qPCR) 
offers greater sensitivity to determine the viral DNA accumulation and is an important tool to establish 
the relation with the resistance [32]. Resistant plants are those that can suppress the multiplication of a 
virus and hence suppress the development of disease symptoms. Tolerance is when plants show no 
symptoms, but the viral DNA is present [33]. Thus, qPCR analysis can be a promising approach to 
study the efficacy of heterologous constructs for virus resistance, epidemiological studies and to 
establish antiviral therapies. The responses of plants to viral infections and to pathogens in general, 
have been studied extensively using several tools (e.g. microarrays, RNA-seq) that allow the 
evaluation of the transcriptome expression in these interactions [34]. These tools are also ideal in 
examining the presence of RNA silencing genes in a host and their expression during  
virus infections [35].  
The present study reports the engineering of two RNAi constructs based on the AC1-IR-AV1 region 
of PepGMV and ToChLPV. We evaluated their efficacy to induce resistance to PepGMV infections in 
Nicotiana benthamiana plants by Agrobacterium-mediated transient assay. Also, we analyzed by 
microarray hybridization the altered mRNAs to detect key components related to silencing pathways. 
 
2. Results  
 
2.1. Development of CIRP (Construct of the Intergenic Region of PepGMV) and CIRT (Construct of 
the Intergenic Region of ToChLPV) Constructs 
 
To evaluate the resistance efficacy against Pepper golden mosaic virus (PepGMV), we engineered 
two hairpin-type (hpRNA) constructs designed to express dsRNA of the AC-IR-AVI segment of 
PepGMV and ToChLPV. The constructs were designed to express an intron-hairpin comprising the 
≈146 nts of the 5´ end of the AV1 gene, the entire (326 nts) intergenic region (IR) and 714 nts of the 5´ 
end of the AC1 gene, the AC1-IR-AV1 segment total comprising 1186 nts (Figure S1). The presence 
of transgenes was detected by PCR.  
 
2.2. Resistance Assays and Determination of Severity, Incidence and Viral Load 
 
The resistance generated by CIRP (Construct of the Intergenic Region of PepGMV) and CIRT 
(Construct of the Intergenic Region of ToChLPV) was determined by challenging N. benthamiana 
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plants with an infectious clone derived from PepGMV. In the resistance analysis, all the non-infected 
plants (negative control) showed a normal phenotype (Figure 1A). All positive control plants 
(inoculated with only PepGMV) developed typical leaf curl symptoms in emergent leaves within 10 
dpi (Figure 1B, Table S1). 
Most N. benthamiana plants infiltrated with either CIRP or CIRT and inoculated with PepGMV, did 
not show severe symptoms or showed only attenuated symptoms (Figure 1C, 1D and Table S1). We 
observed that 5 out of 8 CIRP-protected plants remained symptomless over a period of 10 days, and 
two plants exhibited delayed or attenuated symptoms (foliar severity range 0.5, Table 1) compared 
with PepGMV-inoculated plants (2.5). With CIRT plants, 3 out of the 8 plants remained symptomless 
and three showed mild symptoms and foliar severity range of 1.37. The decrease in severity symptoms 
(efficacy) was 80% in plants protected with CIRP and 45% in plants protected with CIRT (Table 1). 
According to the Mann–Whitney (P≤0.05) test, we found differences in severity between plants 
protected with CIRP and the positive control (unprotected, infected plants). However, no significant 
differences were observed between plants protected with CIRT and the positive control. The presence 
of PepGMV was confirmed by PCR using degenerated primers [36], with a 550 bp amplicon only 
detected in symptomatic plants. Also, the absence of PepGMV was confirmed in all the symptomless 
plants by PCR amplification (Table S1). In incidence reduction, we found a significantly higher 
efficacy of 57.2 % in plants protected with CIRP compared to 42.6% in plants protected with  
CIRT (Table 1).  
 
Figure 1. Comparison of the symptoms of PepGMV-inoculated N. benthamiana plants in 
different bioassay groups. A) Healthy plant used as negative control. B) Plant 10 days after 
inoculation with PepGMV infectious clone (positive control) showing severe leaf curling 
and distortion of the systemic, young leaves. C) Plant agro-infiltrated with CIRP construct 
challenged with PepGMV showing no symptoms. D) PepGMV inoculated, CIRT-protected 
plant showing light to mild symptoms 
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For viral load, the results of the interpolation between the logarithm (log) of the amount of starting 
quantities (SQ) to the amount of the endogenous 18S rRNA gene was y = –3.450x + 13.0, with  
R² = 0.999 (efficiency of 94.9%). The standard curve to PepGMV AV1 gene was y = –3.385x + 18.5, 
with R² = 0.989 (efficiency of 97.4%). 
The curves showed high correlation coefficients and were linear over the concentration range with 
standard and examined DNA. The melting curves of the samples and amplified serial dilutions of the 
gene AV1 showed that the primers did not generate nonspecific products during the amplification. In 
both protected groups of plants, the results suggest that titers of PepGMV are at very low levels, 
compared to positive control (Table 1, Figure 2A). The result of viral DNA accumulation was 
positively correlated with symptom severity, with the lower values found in symptomless plants or in 
plants that exhibited mild symptoms (Table S1). We observed high efficacy in plants protected with 
both constructs in decreasing the viral load. The efficacy observed with CIRT was 95.6% and 99.56% 
with CIRP (Table 1). Also, we found a co-relationship with the significant reduction in the severity (45 
to 80%) and incidence (42.6 to 57.2%) compared with control plants. The average of absolute 
quantification of viral DNA was different (P < 0.05 ANOVA test) in all treatments. The highest value 
observed was in the positive control with 5.22 × 10
-1
 copies. With CIRT we observed 2.27 × 10
-2
 
copies and 2.20 × 10
-3
 copies in CIRP (Figure 2B). Thus, viral accumulation was reduced 19.3- and 
237.2-fold in CIRT and CIRP, respectively, in terms of the control plants. The viral copies with CIRP 
were reduced 12.3-fold compared with CIRT. 
 
Table 1. Summary of findings on comparative effectiveness of two RNAi constructs to 
reduce symptoms, incidence and viral DNA accumulation in experimental PepGMV 
infections. 
1 
Data represent the mean of replicates. 
2
 Data were converted to percentages with the formula present in methodologies and adjusted data as maximum 
value according to positive control (non-protected plants that were inoculated with infectious clone PepGMV). 
Lowercase letters indicated the significant difference among the constructs and positive control at P ≤ 0.05 
(Mann–Whitney test).  
 
 
 
 
  Severity    Incidence   Viral load 
Constructs  Foliar 
severity 
range 1 
Percentage of 
foliar damage 
(%) 2 
Efficacy 
(%) 3 
 PCR 
(+/-) 
Adjusted data 
(%) 
Efficac
y 
(%) 
 Copies Folds Efficacy 
(%) 
CIRT  1.375 55 a 45  4/4 57.4 c 42.6  2.27 × 10-2 c 19.3 95.6 
CIRP  0.50 20 b 80  3/5 42.8 b 57.2  2.20 × 10-3 b 237.3 99.56 
Positive 
control 
 2.5 100 a 0  8/0 100 a 0  5.22 × 10-1 a 1 0 
Viruses 2013, 5                            
 
 
2936 
Figure 2. Real-time PCR amplification. A) Typical amplification plot of qPCR to 
determine mean threshold cycle (Ct) values. Blue line: serial dilutions of PepGMV AV1 
gene plasmid DNA. Yellow line: positive control plants. Green line: plants protected with 
construct CIRT. Red line: plants protected with construct CIRP. B) Standard curves were 
obtained by linear regression of the Ct values of the five standard-dilution replicates over 
the log SQ of the copies of DNA targets. 
 
 
 
2.3. Gene Expression Related to RNAi 
 
To determine whether the efficacy of CIRT and CIRP was due to RNAi, we analyzed the 
transcriptome of N. benthamiana by microarray hybridization to detect the presence of up-regulated 
key components of the silencing pathways. Microarray analysis determined the presence and 
expression of some of the key components that activate the RNAi mechanism. These components were 
found on the lower center (z-score 0.5–1). Components common to both CIRT and CIRP treatments 
were: RNA polymerase IV, DCL3, AGO4, DRD1, DDM1, CMT3, and MET1. Other components of 
RNA silencing were differentially expressed (greater 1.5 up) in either CIRT or CIRP treatments. 
Components particular to CIRT included AT2G35160.1, which encodes SU(var)3-9 homolog 5 
(SUVH5); AT3G15390.1, encoding silencing defective 5 (SDE5); AT3G49500.1, encoding RNA 
dependent RNA polymerase (RDR6); AT4G14200.1, encoding pentatricopeptide repeat (PPR), and 
AT5G23570.1, which encodes SGS3. Components particular to CIRP included AT1G08060.1, 
encoding Morpheus molecule maintenance of methylation (MOM, MOM1); AT1G09700.1, encoding 
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dsRNA-binding protein 1 (DRB1); AT3G22680.1, encoding RNA-directed DNA methylation 1 
(RDM1); AT3G42670.1, encoding chromatin-remodeling 38 (CHR38), and AT4G11130.1, encoding 
RNA-dependent RNA polymerase 2 (RDR2). 
 
2.4. Discussion 
 
Our results provide evidence that both CIRT and CIRP constructs are highly efficient to suppress 
the multiplication of a viral genome and can be explored in the control against PepGMV infections and 
other related species involved in mixed infections. Our results agree with several study groups [37], 
indicating that homologous recognition is highly efficient to induce RNAi. According to the 
hypothesis, we obtained high efficacy of 99.56% (Table 1) in reducing viral DNA with homologous 
construct CIRP. Indeed, complete immunity was observed in most of the protected plants, and viral 
accumulation was reduced 12.3-fold compared with CIRT and 237.3-fold compared with CIRT and 
positive control plants, respectively. With the heterologous CIRT construct we obtained an efficacy of 
95.6% and viral DNA accumulation was reduced 19.3-fold compared with the  
positive control. 
Previous studies mentioned that to obtain optimal results with heterologous RNAi constructs, the 
nucleotide (nt) identity should be at least 85% [38]. Nucleotide alignments of AC1-IR-AV1 segments 
of PepGMV and ToChLPV show identity of 89%. Moreover, we found two 22 nt-long stretches with 
100% similarity: one with 96% and three with 82% (Figure 3). According to the observed, the 
homology was sufficient to trigger an effective reduction in the expression levels of the disease and to 
generate heterologous recognition between CIRT and PepGMV, activating the RNAi mechanism, to 
trigger an effective reduction of the disease in CIRT-protected plants. These results, together with 
those published by others [26-29, 39], add to the conclusion that strong cross-protection can be 
induced by transgenes with sequences AC1, IR or AV1, likely producing high population of siRNAs 
that efficiently activate the silencing process. 
In a partial region of the AC1 gene, we found three ≈24 nt-long (Figure 3) that have 82% 
homologous in ToChLPV and PepGMV. The success in the use of the AC1 gene is that it specifically 
targets the replicase gene with the consequent impact in viral DNA replication [27]. On the other hand, 
other studies [24, 25] have shown that AV1-type constructs can induce the silencing response due to 
the specific recognition of the AV1 gene. Indeed, we found two ≈24 nt-long sequences in the first  
146 nts that were 100% homologous in ToChLPV and PepGMV (Figure 3).  
It has been documented that resistance is broad and effective against strains of the virus from which 
the AV1 gene is derived, or even against closely related virus species. The use of the non-coding IR 
region is an interesting strategy to induce broad resistance against other heterologous geminiviruses. 
This is because the generation of 24 nt siRNAs derived from activity of DCL3 modifies methylation 
processes, which is considered the principal mechanism of antiviral defenses through transcription 
gene silencing [16]. 
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Figure 3. Alignment of region AC1-CR-AV1 from ToChLPV and PepGMV. The six 
regions highlighted in the gray boxes indicate fragments longer than 22 nts of both viruses, 
which show homology from 82% to 100%. 
 
 
 
In addition, it has been reported that dsRNA can be generated by single and specific siRNA that can 
be elongated and consequently generate more specific siRNAs, thereby imparting resistance not only 
against homologous but also against heterologous virus species [26]. The analysis of the transcriptome 
in CIRP- and CIRT-protected plants revealed the expression of some key components of the RNAi 
pathway involved in the formation of primary and secondary viral siRNAs. These RNAi components 
cause changes in the conformation of local chromatin and on the epigenetic regulation resulting in 
gene silencing [40]. This provides evidence of protection to PepGMV based on RNAi in CIRP- and 
CIRT-treated plants. Moreover, we observed that the up-regulated components in CIRT-protected 
plants were different from those observed in CIRP-protected ones. This suggests that the activation of 
the response also depends on the specificity of the sequence used to generate the dsRNA. Disease 
symptoms can be the result of specific interactions between virus and host components [41]. The CIRT 
construct showed a relatively low efficacy in reducing symptom severity and incidence, but a high 
efficacy at reducing the viral DNA. This can be explained because severity is calculated with 
qualitative values and therefore is somehow subjective. Also, the percentages of infection based only 
in conventional PCR depend on the intensity of the signal, and results often lead to underestimate 
quantitative differences [42]. qPCR is a valuable tool in comparing homologous/heterologous RNAi 
constructs since it cannot only quantify viral DNA accumulation, but also correlate, more precisely, 
viral load and the severity of symptoms [43]. In summation, we demonstrated that heterologous RNAi-
type constructs are highly efficient to induce cross-protection and can be an important tool in the 
strategy for control of PepGMV and other Begomovirus-complex diseases. 
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3. Experimental Section 
 
3.1. Development of RNAi Constructs 
 
The construct designed with PepGMV is homologous in respect to the challenging virus (PepGMV) 
and it was named CIRP (Construct of the Intergenic Region of PepGMV). The second construct 
derived from ToChLPV is considered heterologous and it was named CIRT (Construct of the 
Intergenic Region of ToChLPV). The generated amplicons to be used in the constructs were based on 
the degenerate primers PAL1v1978-PAR1c496 [44] with added attB sequences. The amplification was 
carried out with Phusion High-Fidelity DNA Polymerase (Finnzymes) with the following PCR 
parameters: 1 cycle of 98° C/30 s, followed by 30 cycles of 98 °C/10 s, 60 °C/30 s, and 72 °C/30 s. 
The generated products were introduced by BP recombination into the pDONR™ 207 using the 
Gateway system (Invitrogen) according to the manufacturer’s instructions. The resultant products were 
recombined subsequently into binary vector pH7GWIWG2(II) [45], using LR Clonase™ enzyme 
(Gateway®), generating the two expression vectors: CIRP and CIRT. CIRP and CIRT contained 
inverted repeats sequences of the AC1-IR-AV1 region of each virus, including an intron as a spacer 
Restriction digestion analysis was performed with Xbal to confirm the presence of the sense and 
antisense arms and orientation of the inverted repeat sequences. CIRP and CIRT were transformed into 
Agrobacterium tumefaciens GV2260 by electroporation (Bio-Rad Gene Pulser II Electroporator).  
 
3.2. Design of the Experimental Bioassay 
 
3.2.1. Inoculation Assays 
 
N. benthamiana seeds were grown for 30 days in chambers at 28 °C with a photoperiod of 16 h 
light: 8 h dark. To evaluate the protective effect against PepGMV infection and the effectiveness in the 
activation of the RNAi response, we conducted a completely randomized study consisting of four 
treatments: (1) CIRP, plants agro-infiltrated with CIRP and then inoculated with PepGMV four days 
after infiltration; (2) CIRT, plants agro-infiltrated with CIRT and then inoculated with PepGMV four 
days after infiltration; (3) positive control, plants agro-infiltrated with the empty vector 
(pH7GWIWG2(II)) and then inoculated with PepGMV four days after infiltration; and (4) negative 
control, plants agro-infiltrated with the empty vector but not inoculated with PepGMV. Eight plants 
per treatment were agro-infiltrated in the four-leaf stage according to a previously published protocol 
[46]. The inoculations of infectious clones PepGMVAdimpBS and PepGMVBdimpBS (each with two 
genomes in tandem of PepGMV DNA A and DNA B, respectively) were performed by biolistic 
inoculation on the third and fourth agro-infiltrated leaves according to the procedure described in [47]. 
The data were recorded at 10 days post inoculation (dpi).  
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3.2.2. Evaluation of variables  
 
A. Severity  
 
Symptom severity was evaluated based on the following adjusted scale: 0, no visible symptoms; 1, 
presence of visible mild symptoms; 2, some yellowing and minor curling of leaf ends; and 3, severe 
symptoms of curling throughout the plant [5]. The percentage of severity was calculated according to  
[48] with the formula S = (Σi/N [VM])*100, where S = percentage of severity, Σi = sum of observed 
values, N = number of plants observed, and VM = full-scale value. To determine the significant 
differences between groups, we performed the non-parametric Mann–Whitney test (P ≤ 0.05). 
 
B. Incidence  
 
The incidence was calculated based on the detection of viral transcripts by PCR using the 
degenerate primer pair AC1048-AV494 [36]. The formula of percentage of incidence was calculated 
as follows, I (%) = (positive PCR plants/total of inoculated plants)*100. To determine the significant 
differences between groups we performed non-parametric Mann–Whitney test (P ≤ 0.05). 
 
C. Viral Load 
 
The quantification of the PepGMV load was determined by qPCR and it was carried out using 
PepGMVCPq5 and PepGMVCPq3 primers that amplify 104 bp of the AV1 gene [47]. The endogenous 
gene used was 18S rRNA (accession number: X67238) [49]. The reaction mix (10 µL) consisted of  
5 µL of SsoFast
™
EvaGreen (BioRad), 0.1 µL of specific primers (250 µM) and 1 µL of the DNA 
sample and was conducted in 96-well optical plates in the CFX96 qPCR Detection System (BioRad). 
The cycling parameters were as follows: 1 cycle at 95 °C/30 s and 39 cycles each consisting of  
95 °C/0.05 s and 60 °C/20 s. Following amplification, a melting curve analysis program was 
performed to verify the amplified products by their specific melting temperatures (Tm) from 65.0 °C to 
95.0 °C at 0.5 °C/0.05 s increments. For each sample, three replicates were amplified in parallel. Two 
standard curves were prepared: the first from the target gene (plasmid containing the PepGMV AV1 
partial gene) and the second from the internal report (plasmid containing the18S rRNA gene). The 
plasmid was serially diluted 10-fold, from 10 ng DNA/µL. Standard curves were obtained by linear 
regression analyses of the threshold cycle (Ct) value of each of the three standard-dilution replicates 
over the log starting quantity of DNA. Results were expressed as the log of the ratio of the quantity of 
virus DNA [32, 50]. Data acquisition and analyses were performed using the BioRad CFX software 
(version 2.0). qPCR efficacy (E) was calculated by the formula: E = eln 10/−s–1, where a slope (s) of 
−3.322 (E = 2) represents 100% efficacy. Viral load comparisons were performed by one-way 
ANOVA analyses using SSPS statistical software (15.0). 
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3.2.3. Determination of the Efficacy of RNAi Constructs 
 
The efficacy (E) of the RNAi system was calculated as a percentage of reduction of the disease in 
protected plants with respect to unprotected plants and based on the ability to decrease the disease 
severity, incidence and viral load. The efficacy of variables was calculated with the formula:  
E (%) = (value of positive control for each variable – value of treatments (CIRT and CIRP) for each 
variable).  
 
3.3. Microarray Data 
 
Per treatment, i.e. CIRT, CIRP and positive control, two independent biological replicates were 
used to monitor differences in gene expression between treatments. For each biological replicate, three 
leaves from each plant per treatment were harvested, pooled, ﬂash-frozen, ground in liquid nitrogen, 
and stored at –80 ºC. Total RNA was extracted using TRIzol (Invitrogen). Of total RNA, 10 µg were 
used for cDNA synthesis with incorporation of fluorophores Alexa fluor 555 and Alexa fluor 647. An 
equal quantity of labeled cDNA from either CIRT or CIRP was hybridized, together with labeled 
cDNA from controls, to the collection of ‘Arabidopsis thaliana V.3.0.3. microarrays’ for 14 h at 42 ºC, 
using hybridization solution UniHyb (Arraylt). Data acquisition, processing and quantification of the 
images obtained from the microarray hybridization were performed in an Array-Pro Analizer 4000 
with the corresponding software (Packard BioChips). To perform the analysis of microarray data and 
select genes that are significantly differentially expressed between classes of samples, we used the 
genArise package developed by the Computer Unit of the Institute of Cellular Physiology (UNAM). 
Data were normalized and the mean and standard deviation of the distribution of log2 (ratio) values 
were calculated, defining a global fold-change difference and confidence. Genes were considered to be 
differentially expressed with a q value ≤0.05 and a fold change cut off of 1.5 (Z-score). The databases 
Arabidopsis Information Resource (TAIR), Blast2GO, Database for Annotation Visualization and 
Integrate Discovery (DAVID) V6 were used to analyze Gene Ontology (GO). The microarrays data 
have been submitted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/). 
 
4. Conclusions  
 
This study shows that CIRP and CIRT constructs are efficient to induce resistance against infections 
caused by PepGMV in N. benthamiana. We found several up-regulated key components of the RNAi 
pathway. This demonstrates that the protection efficacy is due to the activation of the gene silencing 
mechanism, inducing efficiently an RNA-mediated cross-protection. Heterologous RNAi constructs 
are an interesting model to study antiviral strategies, a step forward for the control of PepGMV, and to 
understand the complex interaction between Begomovirus, RNAi, and the host. 
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